Rectal biopsies weighing 70-34.2 mg (mean 19.3 mg) were taken 6-10 cm proximal to the anus from 40 patients suffering from ulcerative colitis or the irritable colon syndrome (ICS). None was receiving systemic or topical corticosteroid treatment and all but two of the patients with ulcerative colitis were taking sulphasalazine 1-2 g daily.
Biopsies from 26 patients were used to study the effects of prednisolone 8.33 x 10-7M (0.3 t±g/ml) using a laminar flow bioassay method. The biopsies from the other 14 patients were used to confirm the effects of prednisolone 8.33 x 10-7M (0.3 ,ug/ml),
Received for publication 30 October 1980 n= 8, and study those of prednisolone 5.66 x 10-4M
(200 F±g/ml), n=6 by RIA. Details of the patients studied by each method are shown in Table 1 . ORGAN 
CULTURE12
RPMI 1640 containing 25 mM HEPES buffer, 10% fetal calf serum, gentamicin 7.37 x 10-6M (40 ,ug/ml), and amphotericin B 3.13 x 10-7M (0 5 ,ug/ml) was used as culture medium. After excision, rectal biopsies were washed in normal saline at 4°C and a portion removed for histology. The rest of each biopsy was bisected and each half was put into organ culture for up to 40 hours.
The culture medium for one half of each biopsy contained prednisolone (as prednisolone phosphate, pure powder, Organon Laboratories) at a concentration of 8-33 x 10-7M (0 3 ,ug/ml) or 5.66 x 10-4M (200 Vg/ml). The other half was treated identically except that prednisolone was excluded from the culture medium. Addition of prednisolone did not alter the pH of the medium. The Krebs solution contained indomethacin (1 14 x 10-5M, 4 Fg/ml), phenoxybenzamine hydrochloride (2 94 x 10-7M, 01 ,tg/ml), propranolol hydrochloride (7-71 x 10-6M, 2,g/ml), hyoscine hydrobromide (330 x 10-7M, 01 ,g/ml), mepyramine dimaleate (3-51 x 10-7M, 01 ,g/ml), and methysergide dimaleate (5.67 x 10-7M, 0.2 Fg/ml) to render the preparation more specific for PGs. The PGE2 content of each sample was estimated by reference to two closely related standards of authentic PGE2 (bracketing). The coefficient of variation of the assay in this series was 20-6% (intra-assay) and 29.0% (interassay).
PROCEDURE WITH RADIOIMMUNOASSAY
Fourteen pairs of biopsies were removed from organ culture after 16 hours, and PGE2 was measured in the unextracted supernatant by RIA using PGE2 antiserum (Sigma Chemical Co.).'6 The threshold of detection was less than 2-84 fmol (1 pg) and the coefficient of variation of the assay in this series was 7.2 % (intra-assay) and 12.2% (interassay). Crossreactions with PGA2, PGD2, PGE1, PGFla, PGF20c, 6 keto PGFloc thromboxane B2, arachidonic acid, and prednisolone were less than 01%. Authentic PGE2 added to samples was measured accurately (correlation coefficient between added PGE2 and measured increment=099, n=54) and precisely (P <0 001, for increments of 5-67 fmol, 2 pg, n=6).
STATISTICAL METHODS
All data were logarithmically transformed to obtain a normal distribution for analysis. T tests (paired where appropriate) were used, and twotailed values for significance are quoted except for the comparison of doses where one-tailed values were used. Average data are expressed as mean (with 95 % confidence limits) derived from the transformed data.
Results
In preliminary experiments PGE2 was shown to accumulate linearly over at least 40 hours; there was a mean inhibition of 90.8 % by indomethacin 2-8 x 10-7M, 01 ,ug/ml (n=6) suggesting that PGE2 was being synthesised enzymatically. Biopsy specimens boiled for two minutes before organ culture (n=6) did not synthesise PGE2 detectable by bioassay, nor did biopsies placed in normal saline, and these were histologically disorganised within eight hours. By contrast, biopsies in organ culture had intact epithelium on light and electron microscopy, and could incorporate (H3) thymidine after 40 hours in culture. BIOASSAY 
RESULTS
Synthesis of PGE2 over 40 hours measured by bioassay of extracted PGE2-like activity was signi- (P <001) . At the higher concentration of prednisolone (5.66 x 10-4M, 200,g/ml) PGE2 synthesis was further reduced to 7.7 % of control values (P <0001) Table 2 ). This is a significantly greater reduction than that achieved by prednisolone 8.33 x 10-7M (0 3 ,ig/mg) (P <0 05).
Discussion
These results demonstrate that rectal mucosa can synthesise PGE2 in organ culture, that inflamed tissue synthesises greater amounts than uninflamed tissue, and that this can be inhibited by prednisolone.
PGE2 is thought to be the main PG synthesised by rectal mucosa8; it seems likely that its appearance in organ culture represents enzymatic synthesis and is not an artefact of tissue disintegration,'7 as it occurs linearly, is inhibited by indomethacin, and does not occur in boiled or saline controls. We observed somewhat lower rates of synthesis of PGE2 in organ culture than previous workers,5 possibly because most of our patients were taking sulphasalazine. In these and earlier experiments, no apparent differences were seen between biopsies from patients with inactive colitis (on sulphasalazine) and those from patients with the irritable colon syndrome (not on sulphasalazine). Data from each group were pooled to form the uninflamed 'control' group. Although the mean synthesis of PGE2 (measured by bioassay) by inflamed mucosa is about three times higher than by uninflamed mucosa, there is a wide variation in rates of PGE2 synthesis within both groups, whether measured by bioassay or RIA. Hence the difference is significant at the 5 % level only in the larger bioassay series, and differences in the smaller RIA series do not reach significance.
It seems clear that prednisolone has a pronounced inhibitory effect on synthesis of PGE2 by rectal mucosa. The two concentrations of prednisolone 
